EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical Approach to STRIDE-II in Real-Life Settings: Analysis and Practical Recommendations

Elena Ricart iD, Guillermo Bastida, Daniel Carpio, Daniel Ceballos iD, Daniel Ginard, Ignacio Marín-Jimenéz, Luis Menchén, Fernando Muñoz, Yago González-Lama

Crohn's & Colitis 360 · 01.10.2024 · 6 (4)

DOI: 10.1093/crocol/otae055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Crohn's & Colitis 360, online erschienen am 10.10.2024. Verfasst von Elena Ricart und 8 weiteren Autor:innen. Beteiligte Einrichtung: Inflammatory Bowel Disease Unit, Gastroenterology Department, Hospital Clinic Barcelona, IDIBAPS, CIBEREHD, Barcelona 08036, Spain. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ANTHEA, AbbVie.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We aimed to (1) analyze the applicability of the updated Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE-II) recommendations in real-world clinical practice, (2) identify barriers to their implementation, and (3) propose practical measures to overcome these obstacles.

Methods

This qualitative study was based on a survey, a literature review, and expert opinions. Nine inflammatory bowel disease (IBD) experts identified 7 areas likely to be controversial or potential implementation barriers in daily clinical practice: endoscopy, histology, ultrasound, quality of life, biomarkers, symptom control, and patient-reported outcomes (PROs). Based on this, a survey was carried out among educational course participants. The experts discussed the literature review and survey results and proposed several statements and practical actions.

Results

A total of 55 gastroenterologists answered the survey. The reported difficulty level in reaching STRIDE-II treatment goals in clinical practice was high. Only 22% of participants performed clinical remission assessments using clinical indexes and PROs. Seventy percent of responders did not use fecal calprotectin cutoffs and considered changes from the previous levels instead. Mucosal healing as a long-term therapeutic goal was considered necessary to be individualized in specific patient subgroups (eg, elderly/fragile patients, multiple treatment failures, and last-line therapies). Other barriers, like the lack of access to imaging techniques or insufficient knowledge and skills among healthcare professionals, were detected. The experts suggested adding less stringent treatment goals and measurements, patient stratification, local adaptations, educational activities, and research.

Conclusions

STRIDE-II recommendations face various implementation barriers needing careful evaluation in order to enhance their adoption in clinical practice, and ultimately improve outcomes in IBD patients.

Schlagwörter

Stichwörter der Autor:innen

Crohn’s diseaseexpert opinionsimplementationinflammatory bowel diseaseulcerative colitis

Autor:innen und Institutionen

  • Inflammatory Bowel Disease Unit, Gastroenterology Department, Hospital Clinic Barcelona, IDIBAPS, CIBEREHD, Barcelona 08036, Spain.
  • Gastroenterology Department, La Fe University and Polytechnic Hospital, Valencia 46026, Spain.
  • Gastroenterology Department, Complexo Hospitalario Universitario de Pontevedra, Instituto de Investigación Sanitaria Galicia Sur (IISGS), Pontevedra 36071, Spain.
  • Gastroenterology Department, Hospital Universitario Doctor Negrin, Las Palmas de Gran Canaria 35010, Spain.
  • Gastroenterology Department, Hospital Universitario Son Espases, Palma de Mallorca 07120, Spain.
  • Gastroenterology Department, Departamento de Medicina, Facultad de Medicina, Universidad Complutense de Madrid, Hospital Universitario Gregorio Marañón-Instituto de Investigación Sanitaria Gregorio Marañón, Madrid 28007…

ORCID-Profile: Elena Ricart, Daniel Ceballos

Förderung

  • ANTHEA
  • AbbVie

Zitieren

APA

Ricart, E., Bastida, G., Carpio, D., Ceballos, D., Ginard, D., Marín-Jimenéz, I., Menchén, L., Muñoz, F., & González-Lama, Y. (2024). Clinical Approach to STRIDE-II in Real-Life Settings: Analysis and Practical Recommendations. Crohn's & Colitis 360, 6(4). https://doi.org/10.1093/crocol/otae055

Vancouver

Ricart E, Bastida G, Carpio D, Ceballos D, Ginard D, Marín-Jimenéz I, et al. Clinical Approach to STRIDE-II in Real-Life Settings: Analysis and Practical Recommendations. Crohn's & Colitis 360. 2024;6(4). doi:10.1093/crocol/otae055

BibTeX
@article{Ricart2024,
  author = {Ricart, Elena and Bastida, Guillermo and Carpio, Daniel and Ceballos, Daniel and Ginard, Daniel and Marín-Jimenéz, Ignacio and Menchén, Luis and Muñoz, Fernando and González-Lama, Yago},
  title = {Clinical Approach to STRIDE-II in Real-Life Settings: Analysis and Practical Recommendations},
  journal = {Crohn's & Colitis 360},
  year = {2024},
  volume = {6},
  number = {4},
  doi = {10.1093/crocol/otae055}
}
Kostenlos starten →